{"id":1906,"date":"2026-05-11T17:52:37","date_gmt":"2026-05-11T17:52:37","guid":{"rendered":"https:\/\/www.biopharmacentrum.com\/?page_id=1906"},"modified":"2026-05-11T17:54:41","modified_gmt":"2026-05-11T17:54:41","slug":"cdmo-cmo-b2b-partnership-2","status":"publish","type":"page","link":"https:\/\/www.biopharmacentrum.com\/?page_id=1906","title":{"rendered":"CDMO & CMO – B2B Partnership"},"content":{"rendered":"

At\u00a0BioPharma Centrum,<\/strong>\u00a0we specialize in enabling and bridging commercially viable CDMO\/CMO partnerships between innovators, manufacturers, market authorization holders, and commercialization partners globally.<\/span><\/p>\n

Leveraging deep industry expertise and an extensive network of qualified manufacturing partners across India and international markets, we support strategic collaborations for:<\/span><\/p>\n

Finished Dosage Formulations (FDF):<\/strong><\/span><\/h4>\n

We support comprehensive in-licensing and out-licensing opportunities across a wide range of dosage forms, including tablets, capsules, injectables, liquids, semi-solids, ophthalmic, and other specialty formulations. Our approach is focused on identifying commercially viable products and aligning them with the right partners for successful market entry and expansion.<\/span><\/p>\n

We facilitate\u00a0end-to-end partnership models<\/strong>, including\u00a0Principal-to-Principal (P2P)<\/strong>\u00a0and\u00a0License-to-License (L2L\/LL)<\/strong>\u2013based CMO\/CDMO arrangements, ensuring seamless collaboration between product owners, manufacturers, and commercialization partners. Our capabilities extend to\u00a0tender-based supplies<\/strong>, institutional business, and government procurement programs, enabling partners to participate in regulated and high-volume markets. We also support\u00a0market authorization strategies<\/strong>, including product registration, dossier support, regulatory alignment, and lifecycle management across multiple geographies. From product selection and due diligence to technology transfer, scale-up, and commercial supply, we ensure that each engagement is structured for regulatory compliance, supply reliability, and long-term commercial success.<\/span><\/p>\n

API Commercial Supply & Development<\/strong>:<\/span><\/h4>\n

We support the commercial supply and development of a wide range of APIs, including generic molecules, complex chemistries, and differentiated products. Through our network of qualified and regulatory-compliant manufacturing partners, we ensure reliable sourcing aligned with global standards. Our capabilities include\u00a0custom development, process optimization, scale-up, and alternate source identification<\/strong>\u00a0to enhance supply security and cost competitiveness. We also facilitate\u00a0DMF support, regulatory documentation, and lifecycle management<\/strong>, enabling smooth integration into regulated and semi-regulated markets.<\/span><\/p>\n

From early-stage development to long-term commercial supply, we ensure continuity, quality assurance, and strategic alignment with customer requirements. Our strength lies in identifying the right manufacturing and commercialization fit by aligning technical capability, regulatory compliance, commercial feasibility, and long-term strategic objectives.<\/span><\/p>\n

Biologics Drug Substances & Drug Products:<\/strong><\/span><\/h4>\n

We facilitate strategic collaborations for biologics, including drug substances and finished drug products, across multiple therapeutic segments. Our services cover\u00a0sourcing, contract development, manufacturing partnerships, and commercialization support<\/strong>.<\/span><\/p>\n

We work with specialized partners for\u00a0cell line development, upstream and downstream processing, fill-finish operations, and cold chain-enabled supply<\/strong>. Our focus is on ensuring compliance with stringent global regulatory standards while maintaining product integrity and scalability.<\/span><\/p>\n

By aligning technical expertise with market needs, we enable efficient development pathways and reliable supply for biologics and advanced therapies.<\/span><\/p>\n

CDMO \/ CMO \u2013 Deal \/ Agreement Structuring:<\/strong><\/span><\/h4>\n

We specialize in structuring and enabling end-to-end CDMO\/CMO partnerships \/ supply agreements tailored to specific business and market requirements. Our role includes identifying the right partners and facilitating master supply agreements (MSA) covering\u00a0development, scale-up, technology transfer, validation, manufacturing, and long-term supply<\/strong>.<\/span><\/p>\n

We support multiple collaboration models, including\u00a0P2P, License-to-License (L2L\/LL), contract manufacturing, and strategic outsourcing arrangements<\/strong>. Our approach ensures alignment on\u00a0technical capability, regulatory compliance, commercial viability, and risk management<\/strong>. By managing the complexity of multi-party engagements, we enable seamless execution, faster time-to-market, and sustainable, long-term partnerships.<\/span><\/p>\n

From molecule to market \u2014 we connect the right partners for scalable success.<\/strong><\/span><\/p>\n<\/div><\/section><\/div>\n